When it just won’t go away: oral artemisinin monotherapy in Nigeria, threatening lives, threatening progress

BACKGROUND: Oral artemisinin monotherapy (AMT), an important contributor to multi-drug resistant malaria, has been banned in Nigeria. While oral AMT has scarcely been found for several years now in other malaria-endemic countries, availability has persisted in Nigeria’s private sector. In 2015, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ujuju, Chinazo, Anyanti, Jennifer, Newton, Paul N., Ntadom, Godwin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732368/
https://www.ncbi.nlm.nih.gov/pubmed/29246208
http://dx.doi.org/10.1186/s12936-017-2102-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732368/
https://www.ncbi.nlm.nih.gov/pubmed/29246208
http://dx.doi.org/10.1186/s12936-017-2102-7

Ejemplares similares